Cargando…
ONCOGRAM: study protocol for the evaluation of therapeutic response and survival of metastatic colorectal cancer patients treated according to the guidelines of a chemosensitivity assay, the Oncogramme®
BACKGROUND: Colorectal cancer is a major public concern, being the second deadliest cancer in the world. Whereas survival is high for localized forms, metastatic colorectal cancer has showed poor prognosis, with a 5-year survival barely surpassing 11%. Conventional chemotherapies against this diseas...
Autores principales: | Mathonnet, Muriel, Vanderstraete, Mathieu, Bounaix Morand du Puch, Christophe, Giraud, Stéphanie, Lautrette, Christophe, Ouaissi, Mehdi, Tabchouri, Nicolas, Taïbi, Abdelkader, Martin, Renaud, Herafa, Isabelle, Tchalla, Achille, Christou, Niki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379769/ https://www.ncbi.nlm.nih.gov/pubmed/34419125 http://dx.doi.org/10.1186/s13063-021-05531-y |
Ejemplares similares
-
Benefits of functional assays in personalized cancer medicine: more than just a proof-of-concept
por: Bounaix Morand du Puch, Christophe, et al.
Publicado: (2021) -
Chemotherapy outcome predictive effectiveness by the Oncogramme: pilot trial on stage-IV colorectal cancer
por: Bounaix Morand du Puch, Christophe, et al.
Publicado: (2016) -
Stepwise management of hepatocellular carcinoma associated with Abernethy syndrome
por: Christou, Niki, et al.
Publicado: (2018) -
Long‐term survival after surgery of pancreatic primary squamous cell carcinoma: A case report and literature review
por: Taibi, Abdelkader, et al.
Publicado: (2019) -
C-reactive protein is a predictive factor for complications after incisional hernia repair using a biological mesh
por: Janet, Julien, et al.
Publicado: (2021)